These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

39 related items for PubMed ID: 19778718

  • 1. Making strides in peptide-based therapeutics.
    Guarracino DA, Arora PS.
    Chem Biol; 2009 Sep 25; 16(9):919-20. PubMed ID: 19778718
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. HIV-1 gp41: mediator of fusion and target for inhibition.
    Weiss CD.
    AIDS Rev; 2003 Sep 25; 5(4):214-21. PubMed ID: 15012000
    [Abstract] [Full Text] [Related]

  • 6. The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors.
    Gallo SA, Sackett K, Rawat SS, Shai Y, Blumenthal R.
    J Mol Biol; 2004 Jun 25; 340(1):9-14. PubMed ID: 15184018
    [Abstract] [Full Text] [Related]

  • 7. Functional and structural characterization of HIV-1 gp41 ectodomain regions in phospholipid membranes suggests that the fusion-active conformation is extended.
    Korazim O, Sackett K, Shai Y.
    J Mol Biol; 2006 Dec 15; 364(5):1103-17. PubMed ID: 17045292
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Temperature-dependent intermediates in HIV-1 envelope glycoprotein-mediated fusion revealed by inhibitors that target N- and C-terminal helical regions of HIV-1 gp41.
    Gallo SA, Clore GM, Louis JM, Bewley CA, Blumenthal R.
    Biochemistry; 2004 Jun 29; 43(25):8230-3. PubMed ID: 15209519
    [Abstract] [Full Text] [Related]

  • 10. [1,2,6-tri-O-galloyl-beta-D-glucopyranose inhibits gp41-mediated HIV envelope fusion with target cell membrane].
    Sun W, Wang HT, Xia CL, Wu SG, Jiang SB, Jiang ZH, Liu SW.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul 29; 28(7):1127-31. PubMed ID: 18676243
    [Abstract] [Full Text] [Related]

  • 11. Tannin inhibits HIV-1 entry by targeting gp41.
    Lü L, Liu SW, Jiang SB, Wu SG.
    Acta Pharmacol Sin; 2004 Feb 29; 25(2):213-8. PubMed ID: 14769212
    [Abstract] [Full Text] [Related]

  • 12. Fatty acids can substitute the HIV fusion peptide in lipid merging and fusion: an analogy between viral and palmitoylated eukaryotic fusion proteins.
    Lev N, Shai Y.
    J Mol Biol; 2007 Nov 16; 374(1):220-30. PubMed ID: 17919659
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Identification of minimal sequence for HIV-1 fusion inhibitors.
    Nishikawa H, Oishi S, Fujita M, Watanabe K, Tokiwa R, Ohno H, Kodama E, Izumi K, Kajiwara K, Naitoh T, Matsuoka M, Otaka A, Fujii N.
    Bioorg Med Chem; 2008 Oct 15; 16(20):9184-7. PubMed ID: 18819810
    [Abstract] [Full Text] [Related]

  • 17. Artificial ion channel biosensor in human immunodeficiency virus gp41 drug sensing.
    Hou Y, Gochin M.
    Anal Chem; 2008 Aug 01; 80(15):5924-9. PubMed ID: 18590277
    [Abstract] [Full Text] [Related]

  • 18. Mutations conferring resistance to human immunodeficiency virus type 1 fusion inhibitors are restricted by gp41 and Rev-responsive element functions.
    Nameki D, Kodama E, Ikeuchi M, Mabuchi N, Otaka A, Tamamura H, Ohno M, Fujii N, Matsuoka M.
    J Virol; 2005 Jan 01; 79(2):764-70. PubMed ID: 15613304
    [Abstract] [Full Text] [Related]

  • 19. A targeted covalent small molecule inhibitor of HIV-1 fusion.
    Zhou G, He L, Li KH, Pedroso CCS, Gochin M.
    Chem Commun (Camb); 2021 May 06; 57(37):4528-4531. PubMed ID: 33956029
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 2.